Key result
Thoracic radiotherapy in cancer survivors is associated with increased coronary artery calcification over time.
Cohort (n=44)
No
Odds Ratio: 4.5 (95% CI 0.37–54.2)
Absolute Event Rate: 81.8% vs 50%
p-value: p=0.516
Cancer survivors with radiotherapy-associated valvular disease have a high prevalence of concomitant multi-vessel coronary artery calcification, which increases with time since RT, highlighting the value of opportunistic CAC assessment on routine chest CT for risk stratification.
High CAC prevalence in post-RT breast cancer survivors; hypothesis-generating for screening and requires prospective validation before practice change.
Background Thoracic radiotherapy (RT) can cause late radiation-associated cardiac disease including valvular heart disease and coronary artery disease. The burden of concomitant coronary artery calcification (CAC) in survivors with post-RT valvular disease is insufficiently characterised. Purpose To quantify CAC on routine chest computed tomography (CT) in cancer survivors with echocardiographically verified valvular disease after RT, and to explore associations with breast RT laterality, age and time since RT. Methods Single-centre retrospective cohort study (2012–2023) from a cardio-oncology registry. Inclusion required prior thoracic/mediastinal RT, ≥1 valvular abnormality on echocardiography, and an available non-contrast CT. CAC was scored on non-ECG-gated CT using a validated ordinal method: each coronary artery (left main [LM], left anterior descending [LAD], left circumflex [LCx], right coronary artery [RCA]) was graded 0–3 by calcification extent; the summed score (0–12) was categorised as none (0), mild (1–3), moderate (4–6) or severe (7–12). Prevalence was reported with 95% confidence intervals (CI). Fisher’s exact test compared CAC prevalence after left- versus right-sided breast RT. Binomial logistic regression assessed associations of age and years since RT with any CAC. Results Of 62 registry patients, 44 met inclusion criteria (61.4% female; mean age 65.2±12.4 years). Mean time since RT was 19.6±12.7 years. Indications for RT were breast cancer 34.1% (left-sided 25.0%, right-sided 9.1%) and lymphoma 31.8%. Common valvular lesions were mitral regurgitation 59.1%, aortic stenosis 50.0% and aortic regurgitation 36.4%. Median CAC score was 4 (interquartile range 0–9). Any CAC was present in 72.7% (32/44; 95% CI 57.2–85.0); moderate/severe CAC in 50.0% (22/44; 95% CI 34.6–65.4); severe CAC in 41.0% (18/44). LAD had the highest vessel burden (mean 1.55±1.23); median number of affected vessels was 3/4 (interquartile range 0–4). Among breast cancer survivors (n=15), CAC was present in 81.8% (9/11) after left-sided vs 50.0% (2/4) after right-sided RT (p=0.516; OR 4.5, 95% CI 0.37–54.2). In logistic regression (Nagelkerke R2=0.237), years since RT was associated with CAC (OR per year 1.072, 95% CI 1.001–1.149; p=0.046), whereas age was not (p=0.091). Conclusion(s) Cancer survivors with RT-associated valvular disease frequently have multi-vessel CAC on routine CT, with half demonstrating moderate-to-severe burden. Opportunistic CAC assessment on existing chest CT may improve risk stratification and support intensified prevention and/or coronary evaluation when managing radiation-associated valvular disease.
No takes yet. Share an insight, caveat, or question.
Spannbauer et al. (2026) conducted a cohort in Radiotherapy-associated valvular disease in cancer survivors (n=44). Left-sided breast radiotherapy vs. Right-sided breast radiotherapy was evaluated on Presence of any coronary artery calcification (OR 4.5, 95% CI 0.37-54.2, p=0.516). Thoracic radiotherapy in cancer survivors with valvular disease was associated with a 72.7% prevalence of coronary artery calcification, which increased per year since treatment (OR 1.072; p=0.046).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: